The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Methemoglobinemia
Publications
Methemoglobinemia due to local anesthesia: a rare cause of cyanosis and chest pain after placement of implantable cardioverter defibrillator.
Journal of rural medicine : JRM. 2020;15(2):63-64
Methemoglobinemia should be suspected when oxygen saturation apparently decreases after prilocaine infiltration during intravenous sedation.
Clinical case reports. 2018;6(6):1077-1081
Seizures and Methemoglobinemia After Topical Application of Eutectic Mixture of Lidocaine and Prilocaine on a 3.5-Year-Old Child with Molluscum Contagiosum and Atopic Dermatitis.
Pediatric dermatology. 2016;33(5):e284-5
A Case Report of Prilocaine-Induced Methemoglobinemia after Liposuction Procedure.
Case reports in emergency medicine. 2015;2015:282347
[Methaemoglobinaemia in a child treated with Emla(®) cream: circumstances and consequences of overdose].
Annales de dermatologie et de venereologie. 2012;139(12):824-7
Prilocaine induced methaemoglobinaemia in a medically compromised patient. Was this an inevitable consequence of the dose administered?
British dental journal. 2007;203(10):585-7
Prilocaine induced methemoglobinemia.
Saudi medical journal. 2006;27(1):111-3
Methemoglobinemia in an infant receiving nitric oxide after the use of eutectic mixture of local anesthetic.
The Journal of pediatrics. 2002;141(2):285-6
Drug-induced methaemoglobinaemia. Treatment issues.
Drug safety. 1996;14(6):394-405